748
Participants
Start Date
May 31, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
September 30, 2014
Asunaprevir (ASV)
Daclatasvir (DCV)
Pegylated-interferon alfa 2a (PegIFN)
Ribavirin (RBV)
Local Institution, Taipei
Local Institution, Taipei
Local Institution, Taichung
Local Institution, Tainan City
Local Institution, Vienna
Local Institution, Buenos Aires
Local Institution, Vienna
Local Institution, Prov de Santa Fe
Local Institution, Darlinghurst
Local Institution, Randwick
Local Institution, Kogarah
Local Institution, Melbourne
Local Institution, Heidelberg
Local Institution, Clayton
Local Institution, Hamilton
Local Institution, Linz
Local Institution, Adelaide
Local Institution, Salzburg
Local Institution, Bedford Park, Sa
Local Institution, Perth
Local Institution, Nedlands
Local Institution, Wellington
Local Institution, Fremantle
Local Institution, Graz
Weill Cornell Medical College, New York
Local Institution, Torino
North Shore-Long Island Jewish Health System, Manhasset
Local Institution, Berlin
Local Institution, Zafed
Local Institution, Marseille
Local Institution, Berlin
Local Institution, Milan
Local Institution, Hamburg
Johns Hopkins Medical Institutions, Lutherville
University Of North Carolina At Chapel Hill School Of Med, Chapel Hill
Duke University Medical Center, Durham
Carolinas Medical Center, Charlotte
Local Institution, Madrid
Local Institution, Hanover
Local Institution, Toulouse
Local Institution, Haifa
Uf Hepatology Research At Ctrb, Gainesville
The Health Care Authority For Baptist Health, Montgomery
Local Institution, Taichung
Local Institution, Essen
Local Institution, Valencia
Henry Ford Health System, Detroit
Local Institution, Tel Litwinsky
Local Institution, Bonn
Dean Clinic, Madison
Local Institution, Vandœuvre-lès-Nancy
Local Institution, Frankfurt
Washington University School Of Medicine, St Louis
Local Institution, Tel Aviv
Local Institution, Lyon
Local Institution, Paris
Local Institution, Paris
Baylor College Of Medicine, Houston
Vamc, Houston
Alamo Medical Research, San Antonio
University Of Colorado Denver And Hospital, Aurora
Local Institution, München
Scpmg/ Kaiser Permanente Los Angeles Medical Center, Los Angeles
Local Institution, Jerusalem
Local Institution, Jerusalem
Local Institution, Auckland
Scripps Clinic, La Jolla
Local Institution, Clichy
Local Institution, Créteil
Local Institution, Messina
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Saint Petersburg
Local Institution, Smolensk
Local Institution, Samara
Local Institution, Chelyabinsk
Local Institution, Tyumen
Local Institution, Krasnoyarsk
Beth Israel Deaconess Medical Center, Boston
Local Institution, Ciudad de Buenos Aires
Local Institution, Fitzroy
Gastrointestinal Research Institute (G.I.R.I.), Vancouver
Percuro Clinical Research Ltd, Victoria
Toronto General Hospital-University Health Network, Toronto
Toronto Liver Centre, Toronto
Toronto Digestive Disease Associates, Inc., Vaughan
Clinique Medicale Lactuel, Montreal
Jewish General Hospital, Montreal
Alpha-Recherche Clinique, Québec
Local Institution, Dublin
Local Institution, Dublin
Local Institution, Roma
Local Institution, Amsterdam
Local Institution, Leiden
Local Institution, Rotterdam
Local Institution, Bialystok
Local Institution, Wroclaw
Local Institution, Busan
Local Institution, Busan
Local Institution, Busan
Local Institution, Daegu
Local Institution, Daegu
Local Institution, Gyeonggi-do
Local Institution, Gyeongsangnam-do
Local Institution, Incheon
Local Institution, Incheon
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Alicante
Local Institution, Barcelona
Local Institution, London
Local Institution, London
Local Institution, Manchester
Local Institution, Glasgow
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY